Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Ventricular volume expansion in presymptomatic genetic frontotemporal dementia.

Tavares TP, Mitchell DGV, Coleman K, Shoesmith C, Bartha R, Cash DM, Moore KM, van Swieten J, Borroni B, Galimberti D, Tartaglia MC, Rowe J, Graff C, Tagliavini F, Frisoni G, Cappa S, Laforce R Jr, de Mendonça A, Sorbi S, Wallstrom G, Masellis M, Rohrer JD, Finger EC; Genetic FTD Initiative, GENFI.

Neurology. 2019 Oct 2. pii: 10.1212/WNL.0000000000008386. doi: 10.1212/WNL.0000000000008386. [Epub ahead of print]

PMID:
31578297
2.

Genetic Variation in the Ontario Neurodegenerative Disease Research Initiative.

Dilliott AA, Evans EC, Farhan SMK, Ghani M, Sato C, Zhang M, McIntyre AD, Cao H, Racacho L, Robinson JF, Strong MJ, Masellis M, Bulman DE, Rogaeva E, Black SE, Finger E, Frank A, Freedman M, Hassan A, Lang A, Shoesmith CL, Swartz RH, Tang-Wai D, Tartaglia MC, Turnbull J, Zinman L; ONDRI Investigators, Hegele RA.

Can J Neurol Sci. 2019 Sep;46(5):491-498. doi: 10.1017/cjn.2019.228. Epub 2019 Aug 15.

PMID:
31217043
3.

Deceased organ and tissue donation after medical assistance in dying and other conscious and competent donors: guidance for policy.

Downar J, Shemie SD, Gillrie C, Fortin MC, Appleby A, Buchman DZ, Shoesmith C, Goldberg A, Gruben V, Lalani J, Ysebaert D, Wilson L, Sharpe MD; for Canadian Blood Services, the Canadian Critical Care Society, the Canadian Society of Transplantation and the Canadian Association of Critical Care Nurses.

CMAJ. 2019 Jun 3;191(22):E604-E613. doi: 10.1503/cmaj.181648. No abstract available. Erratum in: CMAJ. 2019 Jul 2;191(26):E745.

4.

Toxic diffuse isolated cerebellar edema from over-the-counter health supplements.

Kim DD, Shoesmith C, Ang LC.

Neurology. 2019 May 14;92(20):965-966. doi: 10.1212/WNL.0000000000007510. Epub 2019 Apr 10. No abstract available.

PMID:
30971482
5.

High-dose corticosteroids for acute cytomegalovirus-associated transverse myelitis in the immunocompetent patient: a case report and systematic review.

Budhram A, Liu Y, Krawczyk M, Chan TLH, Burneo JG, Hosseini-Moghaddam SM, Shoesmith C.

J Neurovirol. 2019 Jun;25(3):405-409. doi: 10.1007/s13365-018-0717-2. Epub 2019 Jan 4.

PMID:
30610740
6.

Provincial Differences in the Diagnosis and Care of Amyotrophic Lateral Sclerosis.

Hodgkinson VL, Lounsberry J, Mirian A, Genge A, Benstead T, Briemberg H, Grant I, Hader W, Johnston WS, Kalra S, Linassi G, Massie R, Melanson M, O'Connell C, Schellenberg K, Shoesmith C, Taylor S, Worley S, Zinman L, Korngut L.

Can J Neurol Sci. 2018 Nov;45(6):652-659. doi: 10.1017/cjn.2018.311.

PMID:
30430962
7.

Patterns of Non-Invasive Ventilation in Amyotrophic Lateral Sclerosis.

Markovic N, Povitz M, Smith J, Leasa D, Shoesmith C, Gofton TE.

Can J Neurol Sci. 2018 Jul;45(4):445-450. doi: 10.1017/cjn.2018.25. Epub 2018 Jun 6.

PMID:
29871704
8.

Physician-assisted death: A Canada-wide survey of ALS health care providers.

Abrahao A, Downar J, Pinto H, Dupré N, Izenberg A, Kingston W, Korngut L, O'Connell C, Petrescu N, Shoesmith C, Tandon A, Vargas-Santos AB, Zinman L.

Neurology. 2016 Sep 13;87(11):1152-60. doi: 10.1212/WNL.0000000000002786. Epub 2016 May 13.

9.

Phenotypic and molecular analyses of primary lateral sclerosis.

Mitsumoto H, Nagy PL, Gennings C, Murphy J, Andrews H, Goetz R, Floeter MK, Hupf J, Singleton J, Barohn RJ, Nations S, Shoesmith C, Kasarskis E, Factor-Litvak P.

Neurol Genet. 2015 Apr 14;1(1):e3. doi: 10.1212/01.NXG.0000464294.88607.dd. eCollection 2015 Jun.

10.

Preliminary evaluation of the sensitivity to change of DE-STA motor unit number estimation in the upper trapezius muscle in amyotrophic lateral sclerosis.

Ives CT, Findlater K, Shoesmith CL, Doherty TJ.

Clin Neurophysiol. 2015 Jul;126(7):1427-34. doi: 10.1016/j.clinph.2014.10.013. Epub 2014 Oct 19.

PMID:
25453610
11.

Psychosis and hallucinations in frontotemporal dementia with the C9ORF72 mutation: a detailed clinical cohort.

Kertesz A, Ang LC, Jesso S, MacKinley J, Baker M, Brown P, Shoesmith C, Rademakers R, Finger EC.

Cogn Behav Neurol. 2013 Sep;26(3):146-54. doi: 10.1097/WNN.0000000000000008.

12.

The CNDR: collaborating to translate new therapies for Canadians.

Korngut L, Campbell C, Johnston M, Benstead T, Genge A, Mackenzie A, McCormick A, Biggar D, Bourque P, Briemberg H, O'Connell C, Dojeiji S, Dooley J, Grant I, Hogan G, Johnston W, Kalra S, Katzberg HD, Mah JK, McAdam L, McMillan HJ, Melanson M, Selby K, Shoesmith C, Smith G, Venance SL, Wee J; CNDR Investigator Network.

Can J Neurol Sci. 2013 Sep;40(5):698-704.

PMID:
23968944
13.

Peer recommendations on how to improve clinical research, and Conference wrap-up.

Chad DA, Rowland LP, Armon C, Bedlack R, Durham H, Factor-Litvak P, Heiman-Patterson T, Heitzman D, Lacomis D, Ludolph A, Maragakis N, Miller R, Pattee G, Shoesmith C, Sorenson E, Turner MR.

Amyotroph Lateral Scler Frontotemporal Degener. 2013 May;14 Suppl 1:67-73. doi: 10.3109/21678421.2013.778605.

PMID:
23678882
14.

ALS Untangled No. 20: the Deanna protocol.

ALSUntangled Group, Fournier C, Bedlack B, Hardiman O, Heiman-Patterson T, Gutmann L, Bromberg M, Ostrow L, Carter G, Kabashi E, Bertorini T, Mozaffar T, Andersen P, Dietz J, Gamez J, Dimachkie M, Wang Y, Wicks P, Heywood J, Novella S, Rowland LP, Pioro E, Kinsley L, Mitchell K, Glass J, Sathornsumetee S, Kwiecinski H, Baker J, Atassi N, Forshew D, Ravits J, Conwit R, Jackson C, Sherman A, Dalton K, Tindall K, Gonzalez G, Robertson J, Phillips L, Benatar M, Sorenson E, Shoesmith C, Nash S, Maragakis N, Moore D, Caress J, Boylan K, Armon C, Grosso M, Gerecke B, Wymer J, Oskarsson B, Bowser R, Drory V, Shefner J, Lechtzin N, Leitner M, Miller R, Mitsumoto H, Levine T, Russell J, Sharma K, Saperstein D, McClusky L, MacGowan D, Licht J, Verma A, Strong M, Lomen-Hoerth C, Tandan R, Rivner M, Kolb S, Polak M, Rudnicki S, Kittrell P, Quereshi M, Sachs G, Pattee G, Weiss M, Kissel J, Goldstein J, Rothstein J, Pastula D, Gleb L, Ogino M, Rosenfeld J, Carmi E, Oster C, Barkhaus P, Valor E.

Amyotroph Lateral Scler Frontotemporal Degener. 2013 May;14(4):319-23. doi: 10.3109/21678421.2013.788405. Epub 2013 May 2. Review. No abstract available.

PMID:
23638638
15.

Establishing a Canadian registry of patients with amyotrophic lateral sclerosis.

Korngut L, Genge A, Johnston M, Benstead T, Bourque P, Briemberg H, Casey A, D'Amour M, Dupré N, Figlewicz D, Hader W, Johnston W, Kalra S, Melanson M, O'Connell C, Rouleau G, Shoesmith C, Wee J, Zinman L.

Can J Neurol Sci. 2013 Jan;40(1):29-35.

PMID:
23250124
16.

Regional spread pattern predicts survival in patients with sporadic amyotrophic lateral sclerosis.

Gargiulo-Monachelli GM, Janota F, Bettini M, Shoesmith CL, Strong MJ, Sica RE.

Eur J Neurol. 2012 Jun;19(6):834-41. doi: 10.1111/j.1468-1331.2011.03616.x. Epub 2012 Jan 17.

PMID:
22248150
17.

The happy thrombus sign.

Leung A, Shoesmith C, Bussière M.

Can J Neurol Sci. 2009 Sep;36(5):648-50. No abstract available.

PMID:
19831137
18.

Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, Kalra S, Katz JS, Mitsumoto H, Rosenfeld J, Shoesmith C, Strong MJ, Woolley SC; Quality Standards Subcommittee of the American Academy of Neurology.

Neurology. 2009 Oct 13;73(15):1227-33. doi: 10.1212/WNL.0b013e3181bc01a4. Review.

19.

Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, Kalra S, Katz JS, Mitsumoto H, Rosenfeld J, Shoesmith C, Strong MJ, Woolley SC; Quality Standards Subcommittee of the American Academy of Neurology.

Neurology. 2009 Oct 13;73(15):1218-26. doi: 10.1212/WNL.0b013e3181bc0141. Review. Erratum in: Neurology. 2009 Dec 15;73(24):2134. Neurology. 2010 Mar 2;74(9):781.

20.

Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis.

Strong MJ, Grace GM, Freedman M, Lomen-Hoerth C, Woolley S, Goldstein LH, Murphy J, Shoesmith C, Rosenfeld J, Leigh PN, Bruijn L, Ince P, Figlewicz D.

Amyotroph Lateral Scler. 2009 Jun;10(3):131-46. Erratum in: Amyotroph Lateral Scler. 2009 Aug;10(4):252.

PMID:
19462523
21.

A recipe for ALS.

Shoesmith C.

Can J Neurol Sci. 2008 May;35(2):125-6. No abstract available.

PMID:
18574922
22.

TDP43 is a human low molecular weight neurofilament (hNFL) mRNA-binding protein.

Strong MJ, Volkening K, Hammond R, Yang W, Strong W, Leystra-Lantz C, Shoesmith C.

Mol Cell Neurosci. 2007 Jun;35(2):320-7. Epub 2007 Mar 20.

PMID:
17481916
23.

Amyotrophic lateral sclerosis: update for family physicians.

Shoesmith CL, Strong MJ.

Can Fam Physician. 2006 Dec;52(12):1563-9. Review.

24.

Prognosis of amyotrophic lateral sclerosis with respiratory onset.

Shoesmith CL, Findlater K, Rowe A, Strong MJ.

J Neurol Neurosurg Psychiatry. 2007 Jun;78(6):629-31. Epub 2006 Nov 6.

25.
26.

Soy protein modification of rat polycystic kidney disease.

Ogborn MR, Bankovic-Calic N, Shoesmith C, Buist R, Peeling J.

Am J Physiol. 1998 Mar;274(3):F541-9. doi: 10.1152/ajprenal.1998.274.3.F541.

PMID:
9530270

Supplemental Content

Loading ...
Support Center